May 09, 2021 10:32 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Supreme Court sets up 12-member National Task Force to distribute oxygen | Bengal: BJP leader Mukul Roy rubbishes rumour of his return to TMC | States to get over 53 lakh Covid-19 vaccine doses in next 3 days: Health Ministry | BJP unable to accept people's mandate: Mamata Banerjee in Bengal assembly | India reports over 4-lakh new Covid-19 cases, more than 4,000 deaths in 24 hours

US regulator to authorize Pfizer-BioNTech vaccine for 12-15 year olds next week: Reports

Washinton/Sputnik: The US Food and Drug Administration (FDA) is preparing to approve the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15, The New York Times reported, citing federal officials.

Pfizer in talks with India on vaccine approval; company pledges $70M in medicine donations

Pfizer is discussing with the Indian government expedited approval of its vaccine, company CEO Alber Bourla has said while announcing a donation of medicines worth $70 million to fight the resurgent pandemic.

Pfizer could have first oral drug for COVID-19 by end of year: CEO Bourla

Washington/Sputnik: Pfizer’s experimental oral drug to treat COVID-19 at the first sign of illness could be available before the end of the year, Chief Executive Albert Bourla told CNBC on Tuesday.

Bangladesh to receive 100,000 doses of Pfizer next month

As Bangladesh struggles to procure vaccines from India, officials informed the country would receive around 100,000 doses of Pfizer next month from the WHO’s Covax facility.

Pfizer-BioNTech apply for US authorization to use Its vaccine in adolescents : Statement

Washington/Sputnik: Pfizer and BioNTech said in a statement that they have applied to expand emergency use authorization of their vaccine for usage in adolescents between 12 and 15 years old.

Pfizer- BioNTech seek permission for emergency use of Covid-19 vaccine in adolescents in US

Washington/IBNS: US drug major Pfizer Inc and its German partner BioNTech SE have sought the permission for emergency use of their vaccine in adolescents aged 12 to 15, according to a Reuters report.

BioNTech-Pfizer claims COVID-19 vaccine 100 percent effective on 12-15 years olds

New York: Pfizer Inc. and BioNTech SE on Wednesday announced that, in a Phase 3 trial in adolescents 12 to 15 years of age with or without prior evidence of SARS-CoV-2 infection, the Pfizer-BioNTech COVID-19 vaccine BNT162b2 demonstrated 100% efficacy and robust antibody responses, exceeding those recorded earlier in vaccinated participants aged 16 to 25 years old, and was well tolerated.

US study says Pfizer, Moderna COVID-19 vaccines effective even after first shot in real-world use

Washignton: A new CDC study provides strong evidence that mRNA COVID-19 vaccines are highly effective in preventing SARS-CoV-2 infections in real-world conditions among health care personnel, first responders, and other essential workers.

Japan receives second batch of Pfizer shots against COVID-19: Reports

Tokyo/Sputnik: The second batch of Pfizer coronavirus vaccine doses has been delivered to Japan, the country’s media report.

Pfizer withdraws emergency use request for its Covid-19 vaccine in India

New Delhi/IBNS: Drug manufacturer Pfizer has withdrawn application for emergency use of its coronavirus vaccine in India to provide additional information sought by the drug regulator of India.

Benyamin Netanyahu receives 2nd dose of Covid-19 vaccine, vows all Israelis to be inoculated by March

Tel Aviv/Sputnik: Israeli Prime Minister Benyamin Netanyahu on Saturday received his second dose of the Pfizer/BioNTech coronavirus vaccine live on national television.

Pfizer-funded research claims vaccine might be effective against new Coronavirus strains

Moscow/Sputnik: The efficacy of the Pfizer coronavirus vaccine (official name BNT162b2) might sustain against the newly-detected mutant strains from the United Kingdom and South Africa, a group of US scientists said in a research paper.

Govt's expert panel clears Oxford COVID-19 vaccine for India

New Delhi/IBNS: A government-appointed panel of experts on Friday cleared the Oxford COVID-19 vaccine manufactured by the Serum Institute of India, which will be sent for approval to the regulator Drugs Controller General of India (DCGI).

Govt's expert panel to meet over Covid-19 vaccine approval today

New Delhi/IBNS: An expert panel, appointed by the central government, will on Friday meet over the approval for an emergency use of three Covid-19 vaccines, including an indigenous one.

Allergic reaction to Pfizer Coronavirus vaccine reported in Greece

Athens/Sputnik: One case of an allergic reaction to the Pfizer/BioNTech coronavirus vaccine has been reported in Greece, Primary Health Care Secretary General Marios Themistokleous said at a Health Ministry briefing.